Longaeva Partners’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
Longaeva Partners's ADRX Position: Q3 2026 in Review
Longaeva Partners opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 15,000 shares worth $299K. The stake represents 0.01% of the portfolio and ranks #287 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- Longaeva Partners held 15,000 shares of ADARx Pharmaceuticals worth $299K as of Q3 2026.
- ADARx Pharmaceuticals was a new Longaeva Partners position in Q3 2026.
- ADARx Pharmaceuticals made up 0.01% of Longaeva Partners's portfolio in Q3 2026, its #287 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.